New Hope for Diabetes:
Advanced Stem Cell Therapy
Advanced Stem Cell Therapy Offers Healing From Within
Every day, Rejuve Anti Aging receives inquiries from individuals around the world asking whether stem cell therapy can help with diabetes. The answer is increasingly hopeful: regenerative and stem-cell-derived therapies are showing measurable improvements in metabolic control and, in some cases, dramatically reduced dependence on insulin.
Diabetes is a major global health crisis, affecting more than 540 million people worldwide, with that number projected to approach 783 million by 2045. More than 90 % of cases are type 2 diabetes (T2DM), characterized by insulin resistance, while type 1 diabetes (T1DM) is an autoimmune condition in which insulin-producing pancreatic beta cells are destroyed. Both forms can lead to serious complications affecting the heart, kidneys, nerves, and eyes.
What’s clear is that regenerative therapies are shifting diabetes treatment from symptom management toward biologically restorative approaches. For many patients, these therapies have meant fewer insulin injections, better glucose stability, and an improved ability to engage actively in daily life.
Hope is here — and through stem cell and cell-derived therapies, it’s making a real difference for individuals living with diabetes.
Where Science Meets Hope. Call (949) 787-9800 For Help Today!
A Regenerative Approach That Works
For those living with diabetes, hope is on the horizon. Stem cell therapy is emerging as a promising, minimally invasive regenerative approach that may help address underlying inflammation, support metabolic health, and improve overall quality of life.
Clinical studies and real-world patient experiences have shown encouraging outcomes. Individuals receiving stem cell–based therapies have reported improvements in blood sugar stability, reduced insulin resistance, increased energy levels, and better overall well-being. In some cases, patients have experienced decreased insulin or medication requirements and improvements in markers such as HbA1c and C-peptide, without serious adverse effects.
While stem cell therapy is not a cure for diabetes, it represents a new pathway beyond symptom management alone. By supporting cellular repair and reducing systemic inflammation, regenerative therapy may help patients gain better control over their condition and reduce the risk of long-term complications. With this innovative approach, many individuals are finding renewed confidence, improved daily function, and hope for a healthier, more active future.
How Stem Cell Therapy May Support Patients With Diabetes
Supports Insulin Production and Pancreatic Health
Stem cell therapy may help support the health of pancreatic beta cells—the cells responsible for insulin production. In some patients, regenerative treatments have been associated with increased C-peptide levels, a marker of improved natural insulin output, which may lead to better glucose regulation.
Improves Insulin Sensitivity
Chronic inflammation plays a major role in insulin resistance, especially in type 2 diabetes. Stem cell therapy may help reduce systemic inflammation and improve how the body responds to insulin, allowing glucose to move more efficiently into cells and potentially lowering blood sugar levels.
Helps Reduce Diabetes-Related Inflammation and Complications
Regenerative therapies may support vascular and nerve health by decreasing inflammation and promoting tissue repair. This may help reduce the risk or progression of common diabetes-related complications such as neuropathy, poor circulation, and delayed wound healing.
Enhances Energy, Metabolic Function, and Quality of Life
Many patients report improved energy, mental clarity, and overall well-being following stem cell therapy. By supporting cellular repair and metabolic balance, regenerative treatment may help individuals feel more active, resilient, and better equipped to manage daily life with diabetes.
What Is Stem Cell Therapy
Stem cell therapy is an innovative medical treatment that harnesses the regenerative potential of stem cells to repair, replace, or regenerate damaged tissues and organs. Stem cells are unique because they can differentiate into various cell types and multiply indefinitely, making them essential in regenerative medicine and tissue engineering.
Promotes Natural Healing:
By stimulating tissue repair and regeneration, stem cell therapy addresses the root cause of many conditions, supporting the body’s natural healing processes.
Minimally Invasive Procedure:
Typically administered through injections or infusions, stem cell therapy involves minimally invasive techniques, reducing risks and ensuring a faster recovery.
Personalized Treatment Plans:
Each therapy can be tailored to meet individual patient needs, considering their medical history and treatment goals for more targeted outcomes.
Potential for Long-Lasting Results:
While outcomes vary, many patients experience significant and lasting improvements in symptoms, function, and overall quality of life.
Treatment of Diabetes with Exosomes
If emerging technologies such as mesenchymal stem cell therapy or exosome therapy can demonstrate the ability to slow, halt, or potentially modify the progression of diabetes, they may one day become important components of frontline care. Any regenerative therapy capable of safely supporting metabolic function, reducing inflammation, and protecting insulin-producing cells deserves serious consideration.
Currently, most diabetes treatments focus on managing blood sugar levels rather than addressing the underlying cellular dysfunction, insulin resistance, or beta-cell decline that drive disease progression. Growing research suggests that stem cell–based and exosome therapies may offer a regenerative approach—one that supports tissue repair and may positively influence the course of the disease rather than simply controlling symptoms.
Potential benefits observed in research and clinical settings include:
- Reduction in systemic inflammation, a key driver of insulin resistance
- Improved insulin sensitivity and glucose regulation
- Support of pancreatic and vascular health
- Improved energy levels and reduced fatigue
- Enhanced cellular metabolism and overall metabolic balance
Exosome therapy has not only demonstrated encouraging effects in diabetes research but has also shown potential benefits across other inflammation-driven and metabolic conditions. By supporting intercellular communication and tissue repair, exosomes represent a promising next step in regenerative medicine for chronic disease management.
See What Patients Have Said
However, research suggests that stem cell therapy may help improve metabolic control and reduce the burden of disease for many individuals living with both type 1 and type 2 diabetes.
In a systematic review and meta-analysis of clinical trials involving a total of 226 patients with type 1 diabetes and 386 patients with type 2 diabetes, stem cell-based therapies were associated with significant improvements in key diabetes outcomes. Patients treated with stem cell therapy experienced increases in C-peptide levels (a marker of endogenous insulin production), reductions in HbA1c (a measure of long-term blood glucose control), and lower exogenous insulin requirements compared with baseline measures. For example, in type 2 diabetes cohorts, insulin requirements dropped by an average of roughly 36 units per day after stem cell treatment, alongside improvements in C-peptide and HbA1c values. No significant change in fasting glucose was observed overall, and stem cell therapies were generally well tolerated in these studies.
| Follow-Up Time | UC-MSCs (% of Patients) | Placebo (% of Patients) | p-value |
|---|---|---|---|
| 9 weeks | 8.89 | 2.27 | 0.3607 |
| 20 weeks | 15.56 | 9.09 | 0.3542 |
| 32 weeks | 15.56 | 9.09 | 0.3542 |
| 48 weeks | 20.00 | 4.55 | 0.0268 |
Stem Cell Technology
Harness the power of cutting-edge regenerative science. Stem cells have the unique ability to transform into any type of cell your body needs, promoting natural healing and cellular repair at the site of application. As the foundation of regenerative medicine, these powerful cells adapt to your body’s needs, accelerating recovery and restoring function.
Ethical Sourcing and Screening
Specimen Collection
Advanced Processing Standards
Why Choose Us?
Patients trust Rejuve Anti Aging for results:
Best-in-Class Stem Cells & Exosomes We use the highest-quality, ethically sourced stem cells and exosomes on the market. Our Stem Cell products ensure maximum potency, purity, and safety for faster, more effective healing.
Cost-Effective Without Compromise: Our prices are competitive with overseas providers. We offer competitive pricing right here in the U.S., so you can receive the highest quality care, close to home, without sacrificing safety or results.
Proven Results: Our patients share stories of reduced pain, improved mobility, and a return to activities they thought they’d lost forever. We’re here to help you get back to living your life—safely, naturally, and with hope.
Call us today to book your free consultation.
Take The First Step & Schedule A Free Consultation
References
1. Meta-Analysis of Mesenchymal Stem Cell (MSC) Therapy in Diabetes
A meta-analysis of 10 clinical studies involving 239 patients with type 1 and type 2 diabetes found that MSC therapy was associated with significant improvements in blood glucose control (HbA1c), fasting blood glucose, post-prandial glucose, C-peptide levels (a marker of insulin secretion), and reduced insulin requirements in many cases. These results support the potential of MSC treatment in diabetes management, especially type 1 diabetes. https://stemcellres.biomedcentral.com/articles/10.1186/s13287-021-02342-5
2. Systematic Review Including Hundreds of Patients
A systematic review and meta-analysis comparing stem cell therapy with conventional treatment included 38 original studies with ~654 treated patients and 647 controls, showing that stem cell treatments significantly reduced insulin needs at 6- and 12-month follow-ups.
3. RCT and Larger Meta-Analysis of MSC Therapy
A recent meta-analysis encompassing 507 patients across randomized controlled trials demonstrated improved glycemic control after MSC treatment for both type 1 and type 2 diabetes, including statistically significant reductions in HbA1c and hospital-measured outcomes at around 12 months.
4. Umbilical-Cord MSCs Preserving Beta Cell Function
In a phase I/II randomized, double-blind, placebo-controlled clinical trial of Wharton’s jelly–derived MSCs (ProTrans) in recent-onset type 1 diabetes, participants treated with ProTrans showed preservation of endogenous insulin production (C-peptide levels) over 12 months, whereas placebo patients experienced a significant decline. Insulin needs stayed stable in the treated group versus increased in the placebo group.
5. Stem Cell-Derived Islet Cell Therapy (VX-880)
In a Phase 1/2 open-label study of a stem cell-derived islet cell therapy (VX-880) for type 1 diabetes, all 12 participants restored endogenous insulin production, and 10 out of 12 achieved insulin independence with an average ~92 % reduction in exogenous insulin use. This represents one of the strongest reported clinical outcomes for a regenerative therapy in type 1 diabetes to date. Stem Cell-Derived Islet Therapies Shown to Reduce the Need for Injectable Insulin | American Diabetes Association